Pre-Eclampsia Clinical Trials

35 recruiting

Frequently Asked Questions

Common questions about Pre-Eclampsia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 37 trials

Recruiting

Placental Biology in Health and Disease

PregnancyPre-EclampsiaFetal Growth Restriction (FGR)+3 more
University of Oxford360 enrolled1 locationNCT07470320
Recruiting
Phase 4

A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)

Cardiovascular ComplicationPre-EclampsiaGestational Hypertension+2 more
University of Michigan200 enrolled1 locationNCT06785116
Recruiting
Phase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

Cardiovascular DiseasesHypertensionPregnancy Complications+8 more
Malamo Countouris60 enrolled1 locationNCT06281665
Recruiting
Phase 3

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

Pre-EclampsiaPregnancy Loss
University of Pennsylvania1,150 enrolled1 locationNCT06408181
Recruiting

Mechanisms of Pregnancy Vascular Adaptations

Pre-EclampsiaVascular Diseases
University of Wisconsin, Madison166 enrolled1 locationNCT03806283
Recruiting
Not Applicable

Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset Preeclampsia

Pre-EclampsiaHippocampus
Ankara Etlik City Hospital84 enrolled1 locationNCT07245056
Recruiting
Phase 4

Vitamin D for Preventing Recurrent Preeclampsia in Pregnant Women

Vitamin DPregnancyPre-Eclampsia
Nishtar Medical University146 enrolled1 locationNCT07288801
Recruiting

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)

Pre-EclampsiaOocyte DonationPre-Eclampsia; Complicating Pregnancy+12 more
Copenhagen University Hospital, Hvidovre462 enrolled6 locationsNCT07263490
Recruiting

Autophagy/Apoptosis Balance in Placental Vascular Pathologies

Pregnancy ComplicationsPre-EclampsiaGrowth Retardation, Intrauterine
Centre Hospitalier Universitaire de Nīmes50 enrolled1 locationNCT06779916
Recruiting
Phase 1

Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History

Pre-EclampsiaAbortion, HabitualInfertility Unexplained+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School14 enrolled1 locationNCT06821685
Recruiting
Not Applicable

Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial

ObesityCardiovascular DiseasesHypertension+11 more
University of Pittsburgh454 enrolled1 locationNCT05655936
Recruiting
Not Applicable

Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia

Virtual RealityPre-EclampsiaMaternal Health+2 more
Istanbul University - Cerrahpasa96 enrolled1 locationNCT06893510
Recruiting
Not Applicable

Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women

Pre-EclampsiaGestational HypertensionHypertension Disorders in Pregnancy
Assistance Publique - Hôpitaux de Paris110 enrolled3 locationsNCT04520048
Recruiting
Phase 3

Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

Pre-EclampsiaIntrauterine Growth RestrictionAspirin+3 more
Centre Hospitalier Intercommunal Creteil500 enrolled20 locationsNCT04356326
Recruiting
Not Applicable

Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.

Pre-Eclampsia
Saint Thomas Hospital, Panama200 enrolled1 locationNCT06122220
Recruiting

PEPPI Study: Identification of Women at Risk for Placental Dysfunction

Cardiovascular DiseasesPolycystic Ovary SyndromePre-Eclampsia+4 more
Oulu University Hospital3,000 enrolled1 locationNCT06115122
Recruiting
Not Applicable

Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks

Pre-Eclampsia
St. Olavs Hospital300 enrolled1 locationNCT06108947
Recruiting
Not Applicable

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

Pre-EclampsiaEclampsiaGestational Hypertension+1 more
Northwestern University120 enrolled1 locationNCT06523569
Recruiting

Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies

Arterial StiffnessPre-EclampsiaHigh Risk Pregnancy
McGill University Health Centre/Research Institute of the McGill University Health Centre2,400 enrolled1 locationNCT04783597
Recruiting

Multi-Omics for Maternal Health After Preeclampsia

Pre-EclampsiaPregnancy-induced Hypertension
University of California, San Diego1,100 enrolled1 locationNCT06340152